+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06669832

Digital Monitoring in Cancer Survivors a Feasibility Pilot Combining a Smartwatch and Patient-reported Outcome Measures

Led by Laura Longshaw · Updated on 2025-09-25

50

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

L

Laura Longshaw

Lead Sponsor

B

Bangor University

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a digital monitoring approach for adult cancer survivors to improve their quality of life and symptom management. The study focuses on using routine patient-reported outcomes collected through questionnaires combined with continuous smart watch monitoring. This pilot aims to assess the feasibility of this method and identify factors that might affect participant engagement or satisfaction. Participants will receive a smart watch and either a smart phone or an app on their own phone. The watch will continuously track physical activity, sleep patterns, heart rate, and other data while participants wear it for about 4 months. They will complete weekly symptom questionnaires via MS Forms and attend hospital research appointments at the beginning and end of their involvement. After their participation, a focus group will gather feedback on their experience. The study lasts 18 months overall, with each participant involved for approximately 4 months. Researchers will measure the feasibility of routine self-assessment during this period. Participants health status will be monitored through patient-reported outcomes and smart watch data. The goal is to better understand how digital tools can support cancer survivors during their active surveillance or after treatment completion.

CONDITIONS

Brief Title

Digital Monitoring in Cancer Survivors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of any solid malignancy, at any stage
  • Completed cancer treatments including surgery, radiotherapy, or systemic treatments (hormonal and targeted treatments allowed)
  • Clinical, biochemical, and radiological confirmation of controlled disease
  • Currently on a therapeutic break or completed planned multimodal treatment
  • Scheduled for active surveillance or discharged to surgical or GP care after adjuvant treatment
  • Male or female patients aged 18 years or older
  • WHO Performance Status of 0 to 2
Not Eligible

You will not qualify if you...

  • Not having a SIM card
  • No internet access or unwilling to use mobile data daily
  • Unable to understand or follow instructions independently
  • Having uncontrolled severe comorbidities such as cardiovascular, neurological, or respiratory conditions
  • Lacking capacity to consent
  • Unable to understand English
  • Still undergoing systemic anticancer treatment except bone-targeted agents, hormonal treatment for breast or prostate cancer, or maintenance monoclonal antibody monotherapy
  • Poor general condition with Performance Status greater than 2

Research Team

L

Laura Longshaw

P

Pasquale Innominato

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here